Abarca Health And LucyRx To Merge Into Alternative To Big Three PBMs
Abarca Health and LucyRx are combining to create a large independent pharmacy benefit manager. The new entity will serve more than 9 million members across government and commercial sectors. This merger positions the company as an alternative to the three largest PBMs.
What changed
The new company name is identified as Healthcare Revolution Partners and its membership scale is confirmed at over 9 million.
Live updates
-
Abarca Health and LucyRx Merge to Form Healthcare Revolution Partners
confidence 90%Abarca Health and LucyRx are combining to create a large independent pharmacy benefit manager. The new entity will serve more than 9 million members across government and commercial sectors. This merger positions the company as an alternative to the three largest PBMs.
What's confirmed:
- Abarca Health and LucyRx are combining to create an independent PBM serving more than 9 million members.
- The merged entity is designed for both commercial and government scale.
Still unconfirmed:
- The new company will be named Healthcare Revolution Partners.
- The merger is part of a broader consolidation trend in the PBM market due to rising costs and transparency demands.
-
Abarca Health and LucyRx Merge to Challenge Big Three PBMs
confidence 100%Independent pharmacy benefit managers Abarca Health and LucyRx have agreed to a strategic combination. The merger aims to create a modern PBM capable of commercial and government scale. This move comes as regulators and the public push for lower prescription drug prices.
What's confirmed:
- Abarca Health and LucyRx have agreed to merge.
- The companies are independent pharmacy benefit managers.
- The combined entity will serve 9 million prescription users.
- The transaction will maintain separate brands and leadership teams.
Still unconfirmed:
- The merger may spur more PBM deals this year.
- The merger could reshape the pharmacy benefits sector by providing innovative solutions to challenges posed by traditional PBMs.